This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Yan, L. Articles by Liu, L. Search for Related Content PubMed PubMed Citation Articles by Yan, L. Articles by Liu, L.

Combined Treatment with Temozolomide and Methoxyamine: Blocking Apurininc/Pyrimidinic Site Repair Coupled with Targeting Topoisomerase II

Authors' Affiliation: Department of Medicine, Division of Hematology/Oncology, Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, Ohio

Requests for reprints: Lili Liu, Department of Medicine, Division of Hematology/Oncology, Case Comprehensive Cancer Center, Case Western Reserve University, 10900 Euclid Avenue, Cleveland, OH 44106. Phone: 216-368-5696; Fax: 216-368-1166; E-mail: lxl32{at}case.edu.

Purpose: Methoxyamine has been shown to potentiate the cytotoxic effect of temozolomide both in vitro and in human tumor xenograft models. We postulate that the enhanced cytotoxicity is mediated by methoxyamine-bound apurininc/pyrimidinic (MX-AP) site, a key lesion formed by the combination of temozolomide and methoxyamine. When located within topoisomerase II (topo II) cleavage sites in DNA, MX-AP sites act as dual lethal targets, not only functionally disrupting the base excision repair (BER) pathway but also potentially poisoning topo II.

Experimental Design: Using oligonucleotide substrates, in which a position-specific MX-AP site is located within topo II cleavage sites, we examined the effect of MX-AP site on both AP endonuclease– and topo II–mediated DNA cleavage in vitro.

Results: MX-AP sites were refractory to the catalytic activity of AP endonuclease, indicating their ability to block BER. However, they were cleaved by either purified topo II or nuclear extracts from tumor cells expressing high levels of topo II, suggesting that MX-AP sites stimulate topo II–mediated DNA cleavages. In cells, treatment with temozolomide and methoxyamine increased the expression of topo II and enriched the formation of H2AX foci, which were colocalized with up-regulated topo II, confirming that DNA double-strand breaks marked by H2AX foci are associated with topo II in cells.

Conclusions: Our findings identify a molecular mechanism of cell death whereby MX-AP sites that cumulated in cells due to resistance to BER potentially convert topo II into biotoxins, resulting in enzyme-mediated DNA scission and cell death.

This article has been cited by other articles:

				M. Chen, I. Osman, and S. J. Orlow Antifolate Activity of Pyrimethamine Enhances Temozolomide-Induced Cytotoxicity in Melanoma Cells Mol. Cancer Res., May 1, 2009; 7(5): 703 - 712. [Abstract] [Full Text] [PDF]

				B. Brooks, T. J. O'Brien, S. Ceryak, J. P. Wise Sr, S. S. Wise, J. P. Wise Jr, E. DeFabo, and S. R. Patierno Excision repair is required for genotoxin-induced mutagenesis in mammalian cells Carcinogenesis, May 1, 2008; 29(5): 1064 - 1069. [Abstract] [Full Text] [PDF]